5 unknown. 5 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Unknown 5 |
| Phase 1 | 2 | Unknown 2 |
Follow Phosphorus Metabolism Disorders: new trials by email Literature Review of Phosphorus Metabolism Disorders trials Research Report on Phosphorus Metabolism Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Evaluate the Patient Tolerance, Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate Powder Lanthanum Polystyrene Sulphonate Powder, Lanthanum Carbonate 500 MG, Placebo - Hyperphosphatemia | Phase 1 / Phase 2 | Unknown | Grand Life Science (Liaoning) Co., Ltd. | 48 | 2020-10-21 | 2021-07-28 |
| A Dose Escalation Study of VS-505 in End Stage Renal Disease Patients Undergoing Hemodialysis VS-505 - End Stage Renal Disease, Hyperphosphatemia | Phase 1 / Phase 2 | Unknown | KDL Inc. | 30 | 2015-06-01 | 2016-02-08 |
| Investigating a New Way of Giving Medicine to Newborn and Preterm Babies Oral thin film therapy (Potassium acid phosphate oral thin films), Standard therapy (Potassium acid phosphate oral solution) - Hypophosphataemia, Osteopenia of Prematurity | Phase 2 | Unknown | University of Strathclyde | 20 | 2013-02-01 | 2012-08-31 |
| An Open Label Trial to Evaluate the Effects of a Novel Renal Multivitamin on Inflammation and Other Biomarkers in Endstage Renal Disease Patients Oral Multivitamin - Hyperphosphatemia, Inflammation | Phase 2 | Unknown | Nephrian | 25 | 2009-01-01 | 2009-02-03 |
| Efficacy and Tolerability of ILY101 in Dialysis Patients With Hyperphosphatemia ILY101 - Kidney Diseases, Renal Insufficiency | Phase 2 | Unknown | Ilypsa | 120 | 2006-06-01 | 2007-02-07 |
Hyperphosphatemia (4) · Kidney Diseases (2) · Kidney Failure, Chronic (2) · Bone Diseases, Metabolic (1) · Hypophosphatemia (1) · Inflammation (1) · Premature Birth (1) · Renal Insufficiency (1) · Renal Insufficiency, Chronic (1)
Metabolic Diseases (5) · Nutritional and Metabolic Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (4) · Urogenital Diseases (4) · Chronic Disease (3) · Disease Attributes (3) · Female Urogenital Diseases (3) · Male Urogenital Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Urologic Diseases (3) · Renal Insufficiency (2) · Renal Insufficiency, Chronic (2) · Bone Diseases (1)
Geritol (1) · Solutions (1) · Standard of Care (1) · lanthanum carbonate (1) · potassium phosphate (1)
Grand Life Science (Liaoning) Co., Ltd. (1) · Ilypsa (1) · KDL Inc. (1) · Nephrian (1) · University of Strathclyde (1)
United States (2) · Australia (1) · China (1) · United Kingdom (1)
Alex Mullen (1) · Guido Smeets, MD (1) · Johan Rosman, MD, Ph.D (1) · Ray Chow, PhD (1) · Yanhua Ding, Ph.D (1)